Cleared Traditional

V-PVP (K232125) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K232125 · Vitromed GmbH · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2024
Decision
247d
Days
Class 2
Risk

K232125 is an FDA 510(k) clearance for the V-PVP. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Vitromed GmbH (Langenfeld, DE). The FDA issued a Cleared decision on March 20, 2024 after a review of 247 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitromed GmbH devices

Submission Details

510(k) Number K232125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2023
Decision Date March 20, 2024
Days to Decision 247 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 160d · This submission: 247d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Regulatory Specialists, Inc.
Greg Holland

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQL Media, Reproductive

All 50
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K232125.
Giftlife™ Fertilization Medium
K240149 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jun 2024
Oocyte Flushing & Retrieval Medium
K234023 · Gimbo Medical Technology Shenzhen Co., Ltd. · May 2024
SSS-NX (Serum Substitute Supplement-NX)
K233764 · Fujifilm Irvine Scientific · Apr 2024
G-Vitri™ Vitrification Freeze Media
K232942 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jan 2024
Dewin Blastocyst Medium (with HSA and without HSA)
K231370 · Donnevie Medical Technology (Shanghai) Co. , Ltd. · Aug 2023
V-HYADASE
K222606 · Vitromed GmbH · May 2023